31/01/2008 13:00:00

John LaCour to Speak at the Credit Union Technology Risk Management and Security Summit

MarkMonitor(R), the global leader in enterprise brand protection,

today announced John LaCour, director of AntiPhishing Solutions for

MarkMonitor, will speak at the at the Credit Union Technology Risk

Management and Security Summit in Austin, Texas on February 4.

LaCour will address emerging cybercrime threats in 2008, such as

Rock Phish kits, fast flux networks, and other phishing tactics.

MarkMonitor data shows phishers are targeting a greater breadth of

institutions, with credit unions experiencing 32.6 percent of phishing

attacks in Q3. The MarkMonitor Autumn 2007 Brandjacking Index includes

evidence of increasingly automated phishing site deployment and

management, including techniques to make phishing sites more

resilient. The Credit Union Technology Risk Management and Security

Summit is the largest gathering of information security managers in

the credit union industry. Security experts in the credit union

industry will join LaCour to speak on topics that relate to managing,

analyzing, and preventing risks.

Who: John LaCour, director of AntiPhishing Solutions for

MarkMonitor

What: Credit Union Technology Risk Management and Security Summit,

"Emerging Cybercrime Threats in 2008"

http://www.cuispa.org/cuispa2008/index.php

When: Mon., February 4, 11:15 a.m. CT

Where: Hyatt Regency, 208 Barton Springs Road, Austin, TX 78704

For more information regarding this event, please contact Te Smith

at 831-818-1267 or te.smith@markmonitor.com.

About MarkMonitor

MarkMonitor, the global leader in enterprise brand protection,

offers comprehensive solutions and services that safeguard brands,

reputation and revenue from online risks. With end-to-end solutions

that address the growing threats of online fraud, brand abuse and

unauthorized channels, MarkMonitor enables a secure Internet for

businesses and their customers. The company´s exclusive access to data

combined with its real-time prevention, detection and response

capabilities provide wide-ranging protection to the ever-changing

online risks faced by brands today. For more information, visit

www.markmonitor.com.

Editor´s Notes: MarkMonitor(R) is a registered trademark of

MarkMonitor, Inc. All other trademarks included herein are the

property of their respective owners.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Dec
VELO
Gennemgang og analyse af Veloxis' søgsmålJeg har brugt min aften på at "hygge" mig med Veloxis netop..
65
00:14
 
Det er meget velbeskrevet i talrige bøger og artikler, at tilstandene i store dele af verden udenfor..
32
14 Dec
GEN
Genmab kom sent fredag med en fondbørsmeddelse om en milestone på $3 milloner vedrørende deres DuoBo..
30
18 Dec
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
29
18 Dec
GEN
Med FDA´s godkendelse af Amgens (Micromet) godkendelse af Blincyto (blinatumomab), fik vi for alvor ..
27
18 Dec
PNDORA
Nu har jeg købt og solgt aktier i 8 år og var os her på debatten for 4-5 år siden men har glemt mit ..
24
14 Dec
VWS
Lomborg ved udmærket godt han er på gyngende grund, i mange af hans påstande.   Den værste er, når h..
17
18 Dec
 
  Jeg er gratist, jeg læser med på EI uden at skrive. Det er sjældent, man kan få gratis lunch; men ..
13
14 Dec
MAERSK-B
Husk nu at en produktions nedgang på små 500000 tønder om dagen kan få prisen til at stige markant m..
12
15 Dec
GEN
Genmab har afholdt bestyrelsesmøde og valgt at give bestyrelse, direktion og ledende medarbejdere op..
11

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
MHI Vestas Offshore Wind has received a 258 MW order in the UK
2
Progressive Announces Annual Dividend Information
3
EMGS - Disclosure of large shareholding
4
Hexis Appoints EMEA Executives to Oversee HawkEye and NetBeat Product Lines; Strategic New Hires Help Define Sales Approach and Foster Growth
5
BioAmber Inc : FORM 8-K - Report of unscheduled material events or corporate event

Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 December 2014 16:29:41
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141211.1 - EUROWEB5 - 2014-12-20 17:29:41 - 2014-12-20 16:29:41 - 1000 - Website: OKAY